Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51


miRNAs as radio-response biomarkers for breast cancer stem cells.

Griñán-Lisón C, Olivares-Urbano MA, Jiménez G, López-Ruiz E, Del Val C, Morata-Tarifa C, Entrena JM, González-Ramírez AR, Boulaiz H, Zurita Herrera M, Núñez MI, Marchal JA.

Mol Oncol. 2020 Jan 13. doi: 10.1002/1878-0261.12635. [Epub ahead of print]


Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance.

Yaiza JM, Gloria RA, María Belén GO, Elena LR, Gema J, Juan Antonio M, María Ángel GC, Houria B.

Tissue Cell. 2019 Oct;60:48-59. doi: 10.1016/j.tice.2019.07.005. Epub 2019 Aug 3.


LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy.

Jiménez-Martínez Y, Griñán-Lisón C, Khaldy H, Martín A, Cambrils A, Ibáñez Grau A, Jiménez G, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1016. doi: 10.3390/cancers11071016.


Phenformin as an Anticancer Agent: Challenges and Prospects.

García Rubiño ME, Carrillo E, Ruiz Alcalá G, Domínguez-Martín A, A Marchal J, Boulaiz H.

Int J Mol Sci. 2019 Jul 5;20(13). pii: E3316. doi: 10.3390/ijms20133316. Review.


Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin.

Cáceres B, Ramirez A, Carrillo E, Jimenez G, Griñán-Lisón C, López-Ruiz E, Jiménez-Martínez Y, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Feb 23;11(2). pii: E264. doi: 10.3390/cancers11020264.


Clinical Trials of Thermosensitive Nanomaterials: An Overview.

Nardecchia S, Sánchez-Moreno P, Vicente J, Marchal JA, Boulaiz H.

Nanomaterials (Basel). 2019 Feb 2;9(2). pii: E191. doi: 10.3390/nano9020191. Review.


Thermo-Sensitive Nanomaterials: Recent Advance in Synthesis and Biomedical Applications.

Sánchez-Moreno P, de Vicente J, Nardecchia S, Marchal JA, Boulaiz H.

Nanomaterials (Basel). 2018 Nov 13;8(11). pii: E935. doi: 10.3390/nano8110935. Review.


Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells.

Ramírez A, Conejo-García A, Griñán-Lisón C, López-Cara LC, Jiménez G, Campos JM, Marchal JA, Boulaiz H.

Front Pharmacol. 2018 Jul 26;9:798. doi: 10.3389/fphar.2018.00798. eCollection 2018.


Recent Progress in Gene Therapy for Ovarian Cancer.

Áyen Á, Jiménez Martínez Y, Marchal JA, Boulaiz H.

Int J Mol Sci. 2018 Jun 30;19(7). pii: E1930. doi: 10.3390/ijms19071930. Review.


Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile.

Jiménez G, Hackenberg M, Catalina P, Boulaiz H, Griñán-Lisón C, García MÁ, Perán M, López-Ruiz E, Ramírez A, Morata-Tarifa C, Carrasco E, Aguilera M, Marchal JA.

Cancer Lett. 2018 Aug 10;429:78-88. doi: 10.1016/j.canlet.2018.04.042. Epub 2018 May 5.


What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).

Boulaiz H, Ramos MC, Griñán-Lisón C, García-Rubiño ME, Vicente F, Marchal JA.

Expert Opin Ther Pat. 2017 Dec;27(12):1319-1328. doi: 10.1080/13543776.2017.1379991. Epub 2017 Sep 21. Review.


What's new in treatment of pancreatic cancer: a patent review (2010-2017).

Ramos MC, Boulaiz H, Griñan-Lison C, Marchal JA, Vicente F.

Expert Opin Ther Pat. 2017 Nov;27(11):1251-1266. doi: 10.1080/13543776.2017.1349106. Epub 2017 Jul 12. Review.


Cancer suicide gene therapy: a patent review.

Navarro SA, Carrillo E, Griñán-Lisón C, Martín A, Perán M, Marchal JA, Boulaiz H.

Expert Opin Ther Pat. 2016 Sep;26(9):1095-104. doi: 10.1080/13543776.2016.1211640. Epub 2016 Jul 20. Review.


Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?

López-Ruiz E, Jiménez G, García MÁ, Antich C, Boulaiz H, Marchal JA, Perán M.

Expert Opin Ther Pat. 2016 Aug;26(8):877-90. doi: 10.1080/13543776.2016.1203903. Epub 2016 Jul 8. Review.


Smart Drug-Delivery Systems for Cancer Nanotherapy.

Sanchez-Moreno P, Ortega-Vinuesa JL, Peula-Garcia JM, Marchal JA, Boulaiz H.

Curr Drug Targets. 2018 Feb 19;19(4):339-359. doi: 10.2174/1389450117666160527142544. Review.


HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.

Ramírez A, Boulaiz H, Morata-Tarifa C, Perán M, Jiménez G, Picon-Ruiz M, Agil A, Cruz-López O, Conejo-García A, Campos JM, Sánchez A, García MA, Marchal JA.

Oncotarget. 2014 Jun 15;5(11):3590-606.


Synthesis and characterization of lipid immuno-nanocapsules for directed drug delivery: selective antitumor activity against HER2 positive breast-cancer cells.

Sánchez-Moreno P, Ortega-Vinuesa JL, Boulaiz H, Marchal JA, Peula-García JM.

Biomacromolecules. 2013 Dec 9;14(12):4248-59. doi: 10.1021/bm401103t. Epub 2013 Nov 4.


Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil.

Asara Y, Marchal JA, Carrasco E, Boulaiz H, Solinas G, Bandiera P, Garcia MA, Farace C, Montella A, Madeddu R.

Int J Mol Sci. 2013 Aug 12;14(8):16600-16. doi: 10.3390/ijms140816600.


A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin.

Boulaiz H, Aránega A, Cáceres B, Alvarez P, Serrano-Rodríguez F, Carrillo E, Melguizo C, Prados J.

BioDrugs. 2014 Feb;28(1):63-74. doi: 10.1007/s40259-013-0055-0. Erratum in: BioDrugs. 2014 Feb;28(1):121. Blanca, Cáceres [corrected to Cáceres, Blanca]; Pablo, Alvarez [corrected to Alvares, Pablo]; Fernando, Rodrigues-Serrano [corrected to Serrano-Rodríguez, Fernando]; Esmeralda, Carrillo [corrected to Carrillo, Esmeralda]; Consolación, Melguizo [correct.


Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.

Ortiz R, Prados J, Melguizo C, Rama AR, Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H, Aranega A.

Biomed Pharmacother. 2012 Oct;66(7):563-7. doi: 10.1016/j.biopha.2012.05.004. Epub 2012 Jun 19.


Supplemental Content

Loading ...
Support Center